Stockreport

4D Molecular Therapeutics Full Year 2024 Earnings: Misses Expectations [Yahoo! Finance]

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF US$2.98 loss per share (further deteriorated from US$2.58 loss in FY 2023). NasdaqGS:FDMT Earnings and Revenue Growth March 2nd 2025 All figures shown in the chart [Read more]